药效-话题@MedSci

#药效#

48篇内容 | 1149人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1672326, encodeId=251916e232621, content=<a href='/topic/show?id=2f3a8e59170' target=_blank style='color:#2F92EE;'>#药效#</a>, objectTitle=吃药姿势有讲究：姿势不对，影响药效！, objectType=article, longId=737496, objectId=b677e3749674, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b677e3749674, replyNumber=0, likeNumber=51, createdTime=2023-03-18, rootId=0, userName=lsndxfj, userId=189026903389, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b677e3749674, moduleTitle=吃药姿势有讲究：姿势不对，影响药效！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b677e3749674)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1672324, encodeId=fe1d16e232421, content=<a href='/topic/show?id=2f3a8e59170' target=_blank style='color:#2F92EE;'>#药效#</a>, objectTitle=Nat Metab：用于治疗苯丙酮尿症的工程化大肠杆菌菌株的安全性和药效学研究, objectType=article, longId=214950, objectId=b67b2149501e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b67b2149501e, replyNumber=0, likeNumber=34, createdTime=2022-05-03, rootId=0, userName=lsndxfj, userId=189026903389, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b67b2149501e, moduleTitle=Nat Metab：用于治疗苯丙酮尿症的工程化大肠杆菌菌株的安全性和药效学研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b67b2149501e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1672325, encodeId=86c616e232527, content=<a href='/topic/show?id=2f3a8e59170' target=_blank style='color:#2F92EE;'>#药效#</a>, objectTitle=Arthritis Rheumatol：Bruton‘s酪氨酸激酶抑制剂Fenebrutinib治疗系统性红斑狼疮的疗效、安全性和药效学效应研究, objectType=article, longId=301207, objectId=11cf30120ed4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=11cf30120ed4, replyNumber=0, likeNumber=39, createdTime=2023-02-10, rootId=0, userName=lsndxfj, userId=189026903389, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=11cf30120ed4, moduleTitle=Arthritis Rheumatol：Bruton‘s酪氨酸激酶抑制剂Fenebrutinib治疗系统性红斑狼疮的疗效、安全性和药效学效应研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=11cf30120ed4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1672322, encodeId=6dfe16e23226b, content=<a href='/topic/show?id=2f3a8e59170' target=_blank style='color:#2F92EE;'>#药效#</a>, objectTitle=降脂神药！一年给药2次，药效持续17个月，诺华的siPCSK9疗法inclisiran获得欧洲CHMP的正面评价, objectType=article, longId=202221, objectId=a2c720222179, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a2c720222179, replyNumber=0, likeNumber=50, createdTime=2020-11-01, rootId=0, userName=lsndxfj, userId=189026903389, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a2c720222179, moduleTitle=降脂神药！一年给药2次，药效持续17个月，诺华的siPCSK9疗法inclisiran获得欧洲CHMP的正面评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a2c720222179)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1672323, encodeId=918016e23230c, content=<a href='/topic/show?id=2f3a8e59170' target=_blank style='color:#2F92EE;'>#药效#</a>, objectTitle=Clin Cancer Res：预测仑伐替尼（Lenvatinib）在不可切除肝细胞癌中生存获益的药效学生物标志物:来自III期REFLECT研究, objectType=article, longId=214268, objectId=9fbc2142681c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9fbc2142681c, replyNumber=0, likeNumber=53, createdTime=2022-04-22, rootId=0, userName=lsndxfj, userId=189026903389, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9fbc2142681c, moduleTitle=Clin Cancer Res：预测仑伐替尼（Lenvatinib）在不可切除肝细胞癌中生存获益的药效学生物标志物:来自III期REFLECT研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9fbc2142681c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1672320, encodeId=45a616e2320d9, content=<a href='/topic/show?id=2f3a8e59170' target=_blank style='color:#2F92EE;'>#药效#</a>, objectTitle=拜耳收购不依赖激素的女性避孕产品Ovaprene，药效可维持1个月, objectType=article, longId=186396, objectId=9ac8186396fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9ac8186396fa, replyNumber=0, likeNumber=51, createdTime=2020-01-24, rootId=0, userName=lsndxfj, userId=189026903389, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9ac8186396fa, moduleTitle=拜耳收购不依赖激素的女性避孕产品Ovaprene，药效可维持1个月, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9ac8186396fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1672321, encodeId=8c0516e232194, content=<a href='/topic/show?id=2f3a8e59170' target=_blank style='color:#2F92EE;'>#药效#</a>, objectTitle=“神药”羟氯喹药效之争, objectType=article, longId=192192, objectId=346f19219231, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=346f19219231, replyNumber=0, likeNumber=34, createdTime=2020-05-24, rootId=0, userName=lsndxfj, userId=189026903389, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=346f19219231, moduleTitle=“神药”羟氯喹药效之争, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=346f19219231)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1672318, encodeId=a5c616e2318e0, content=<a href='/topic/show?id=2f3a8e59170' target=_blank style='color:#2F92EE;'>#药效#</a>, objectTitle=辉瑞的Duchenne肌营养不良症基因疗法1b期展现出药效，但是安全问题引发了竞争对手股价上涨, objectType=article, longId=174689, objectId=57431e468941, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=57431e468941, replyNumber=0, likeNumber=33, createdTime=2020-04-15, rootId=0, userName=lsndxfj, userId=189026903389, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=57431e468941, moduleTitle=辉瑞的Duchenne肌营养不良症基因疗法1b期展现出药效，但是安全问题引发了竞争对手股价上涨, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=57431e468941)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1672317, encodeId=50b616e2317bd, content=<a href='/topic/show?id=2f3a8e59170' target=_blank style='color:#2F92EE;'>#药效#</a>, objectTitle=尼古丁和烟草研究协会（SRNT）年会：I / II期试验阐明了Cytisinicline的多剂量、药代动力学和药效学特征, objectType=article, longId=161124, objectId=282916112457, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=282916112457, replyNumber=0, likeNumber=42, createdTime=2019-11-17, rootId=0, userName=lsndxfj, userId=189026903389, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=282916112457, moduleTitle=尼古丁和烟草研究协会（SRNT）年会：I / II期试验阐明了Cytisinicline的多剂量、药代动力学和药效学特征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=282916112457)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1672319, encodeId=4abe16e23197f, content=<a href='/topic/show?id=2f3a8e59170' target=_blank style='color:#2F92EE;'>#药效#</a>, objectTitle=Clin Chem：偶尔和长期吸食大麻者模拟驾驶对警惕性和事故风险的影响及其药代动力学-药效学关系, objectType=article, longId=175893, objectId=0c821e5893d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0c821e5893d6, replyNumber=0, likeNumber=52, createdTime=2020-05-01, rootId=0, userName=lsndxfj, userId=189026903389, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0c821e5893d6, moduleTitle=Clin Chem：偶尔和长期吸食大麻者模拟驾驶对警惕性和事故风险的影响及其药代动力学-药效学关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0c821e5893d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1672316, encodeId=f18916e23168f, content=<a href='/topic/show?id=2f3a8e59170' target=_blank style='color:#2F92EE;'>#药效#</a>, objectTitle=Diabetic Med：钠-葡萄糖共转运蛋白-2抑制剂依帕列净在2型糖尿病年轻人中的药代动力学和药效学特征, objectType=article, longId=152526, objectId=ad2715252671, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad2715252671, replyNumber=0, likeNumber=38, createdTime=2019-04-26, rootId=0, userName=lsndxfj, userId=189026903389, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad2715252671, moduleTitle=Diabetic Med：钠-葡萄糖共转运蛋白-2抑制剂依帕列净在2型糖尿病年轻人中的药代动力学和药效学特征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ad2715252671)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1672314, encodeId=73ef16e2314e9, content=<a href='/topic/show?id=2f3a8e59170' target=_blank style='color:#2F92EE;'>#药效#</a>, objectTitle=Nat Commun：辨色识癌！MIT这种新技术可有效预测化疗药效果, objectType=article, longId=146230, objectId=b9041462305f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b9041462305f, replyNumber=0, likeNumber=48, createdTime=2019-01-25, rootId=0, userName=lsndxfj, userId=189026903389, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b9041462305f, moduleTitle=Nat Commun：辨色识癌！MIT这种新技术可有效预测化疗药效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b9041462305f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1672312, encodeId=d21616e231249, content=<a href='/topic/show?id=2f3a8e59170' target=_blank style='color:#2F92EE;'>#药效#</a>, objectTitle=Science：只要药效，不要副作用！真实论文告诉你这不是空想, objectType=article, longId=137997, objectId=998913e997da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=998913e997da, replyNumber=0, likeNumber=49, createdTime=2019-04-01, rootId=0, userName=lsndxfj, userId=189026903389, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=998913e997da, moduleTitle=Science：只要药效，不要副作用！真实论文告诉你这不是空想, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=998913e997da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1672311, encodeId=294116e23111f, content=<a href='/topic/show?id=2f3a8e59170' target=_blank style='color:#2F92EE;'>#药效#</a>, objectTitle=奥美拉唑如何更好发挥药效, objectType=article, longId=132641, objectId=40c213264132, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=40c213264132, replyNumber=0, likeNumber=36, createdTime=2018-05-12, rootId=0, userName=lsndxfj, userId=189026903389, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=40c213264132, moduleTitle=奥美拉唑如何更好发挥药效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=40c213264132)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1672313, encodeId=3b2916e2313cd, content=<a href='/topic/show?id=2f3a8e59170' target=_blank style='color:#2F92EE;'>#药效#</a>, objectTitle=抗菌药物药代动力学/药效学理论临床应用专家共识, objectType=article, longId=141580, objectId=c267141580eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c267141580eb, replyNumber=0, likeNumber=33, createdTime=2018-07-28, rootId=0, userName=lsndxfj, userId=189026903389, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c267141580eb, moduleTitle=抗菌药物药代动力学/药效学理论临床应用专家共识, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c267141580eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1672315, encodeId=427b16e2315d6, content=<a href='/topic/show?id=2f3a8e59170' target=_blank style='color:#2F92EE;'>#药效#</a>, objectTitle=Daiichi宣布开展临床试验：评价其在研抗体偶联药物和Keytruda联合治疗乳腺癌和肺癌的药效, objectType=article, longId=149488, objectId=4ea8149488e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ea8149488e4, replyNumber=0, likeNumber=34, createdTime=2019-01-09, rootId=0, userName=lsndxfj, userId=189026903389, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ea8149488e4, moduleTitle=Daiichi宣布开展临床试验：评价其在研抗体偶联药物和Keytruda联合治疗乳腺癌和肺癌的药效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4ea8149488e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1672310, encodeId=aeb516e23109c, content=<a href='/topic/show?id=2f3a8e59170' target=_blank style='color:#2F92EE;'>#药效#</a>, objectTitle=仿制药药效将比肩原研药药费有望下降, objectType=article, longId=126029, objectId=0f0f126029fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f0f126029fc, replyNumber=0, likeNumber=33, createdTime=2018-07-28, rootId=0, userName=lsndxfj, userId=189026903389, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f0f126029fc, moduleTitle=仿制药药效将比肩原研药药费有望下降, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f0f126029fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1672309, encodeId=720516e2309b8, content=<a href='/topic/show?id=2f3a8e59170' target=_blank style='color:#2F92EE;'>#药效#</a>, objectTitle=JAMA Pediatr：肺炎住院儿童：β-内酰胺联合大环内酯类真比单药效果好？, objectType=article, longId=125955, objectId=e32112595588, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e32112595588, replyNumber=0, likeNumber=36, createdTime=2018-04-23, rootId=0, userName=lsndxfj, userId=189026903389, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e32112595588, moduleTitle=JAMA Pediatr：肺炎住院儿童：β-内酰胺联合大环内酯类真比单药效果好？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e32112595588)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1672305, encodeId=2f7f16e230590, content=<a href='/topic/show?id=2f3a8e59170' target=_blank style='color:#2F92EE;'>#药效#</a>, objectTitle=Proc Natl Acad Sci USA：科学家发现一种强效止痛药，比常规止痛药效果好且副作用少！, objectType=article, longId=109103, objectId=399110910374, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=399110910374, replyNumber=0, likeNumber=52, createdTime=2018-01-16, rootId=0, userName=lsndxfj, userId=189026903389, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=399110910374, moduleTitle=Proc Natl Acad Sci USA：科学家发现一种强效止痛药，比常规止痛药效果好且副作用少！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=399110910374)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1672295, encodeId=ba4616e229539, content=<a href='/topic/show?id=2f3a8e59170' target=_blank style='color:#2F92EE;'>#药效#</a>, objectTitle=Diabetes Care：非2型糖尿病超重和肥胖患者Canagliflozin和芬特明联合用药效果如何？, objectType=article, longId=91797, objectId=034891e9757, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=034891e9757, replyNumber=0, likeNumber=38, createdTime=2017-12-25, rootId=0, userName=lsndxfj, userId=189026903389, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=034891e9757, moduleTitle=Diabetes Care：非2型糖尿病超重和肥胖患者Canagliflozin和芬特明联合用药效果如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=034891e9757)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

药效

2020-05-29

lsndxfj (审核中...)

前往app查看评论内容

#药效#

吃药姿势有讲究：姿势不对，影响药效！

2023-03-18

lsndxfj (审核中...)

前往app查看评论内容

#药效#

Nat Metab：用于治疗苯丙酮尿症的工程化大肠杆菌菌株的安全性和药效学研究

2022-05-03

lsndxfj (审核中...)

前往app查看评论内容

#药效#

Arthritis Rheumatol：Bruton‘s酪氨酸激酶抑制剂Fenebrutinib治疗系统性红斑狼疮的疗效、安全性和药效学效应研究

2023-02-10

lsndxfj (审核中...)

前往app查看评论内容

#药效#

降脂神药！一年给药2次，药效持续17个月，诺华的siPCSK9疗法inclisiran获得欧洲CHMP的正面评价

2020-11-01

lsndxfj (审核中...)

前往app查看评论内容

#药效#

Clin Cancer Res：预测仑伐替尼（Lenvatinib）在不可切除肝细胞癌中生存获益的药效学生物标志物:来自III期REFLECT研究

2022-04-22

lsndxfj (审核中...)

前往app查看评论内容

#药效#

拜耳收购不依赖激素的女性避孕产品Ovaprene，药效可维持1个月

2020-01-24

lsndxfj (审核中...)

前往app查看评论内容

#药效#

“神药”羟氯喹药效之争

2020-05-24

lsndxfj (审核中...)

前往app查看评论内容

#药效#

辉瑞的Duchenne肌营养不良症基因疗法1b期展现出药效，但是安全问题引发了竞争对手股价上涨

2020-04-15

lsndxfj (审核中...)

前往app查看评论内容

#药效#

尼古丁和烟草研究协会（SRNT）年会：I / II期试验阐明了Cytisinicline的多剂量、药代动力学和药效学特征

2019-11-17

lsndxfj (审核中...)

前往app查看评论内容

#药效#

Clin Chem：偶尔和长期吸食大麻者模拟驾驶对警惕性和事故风险的影响及其药代动力学-药效学关系

2020-05-01

lsndxfj (审核中...)

前往app查看评论内容

#药效#

Diabetic Med：钠-葡萄糖共转运蛋白-2抑制剂依帕列净在2型糖尿病年轻人中的药代动力学和药效学特征

2019-04-26

lsndxfj (审核中...)

前往app查看评论内容

#药效#

Nat Commun：辨色识癌！MIT这种新技术可有效预测化疗药效果

2019-01-25

lsndxfj (审核中...)

前往app查看评论内容

#药效#

Science：只要药效，不要副作用！真实论文告诉你这不是空想

2019-04-01

lsndxfj (审核中...)

前往app查看评论内容

#药效#

奥美拉唑如何更好发挥药效

2018-05-12

lsndxfj (审核中...)

前往app查看评论内容

#药效#

抗菌药物药代动力学/药效学理论临床应用专家共识

2018-07-28

lsndxfj (审核中...)

前往app查看评论内容

#药效#

Daiichi宣布开展临床试验：评价其在研抗体偶联药物和Keytruda联合治疗乳腺癌和肺癌的药效

2019-01-09

lsndxfj (审核中...)

前往app查看评论内容

#药效#

仿制药药效将比肩原研药药费有望下降

2018-07-28

lsndxfj (审核中...)

前往app查看评论内容

#药效#

JAMA Pediatr：肺炎住院儿童：β-内酰胺联合大环内酯类真比单药效果好？

2018-04-23

lsndxfj (审核中...)

前往app查看评论内容

#药效#

Proc Natl Acad Sci USA：科学家发现一种强效止痛药，比常规止痛药效果好且副作用少！

2018-01-16

lsndxfj (审核中...)

前往app查看评论内容

#药效#

Diabetes Care：非2型糖尿病超重和肥胖患者Canagliflozin和芬特明联合用药效果如何？

2017-12-25

科室
- - 订阅+
  - 更多科室
工具
服务